Meerkat: Monitoring Key Activity and Physiology of Neonates in Intensive Care

Sponsor
Cambridge University Hospitals NHS Foundation Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04831242
Collaborator
(none)
48
19

Study Details

Study Description

Brief Summary

To optimise and evaluate a novel non-contact physiological monitoring system in the neonatal intensive care unit (NICU)

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    To optimise and evaluate a novel non-contact physiological monitoring system in the neonatal intensive care unit (NICU)

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    48 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Monitoring Key Activity and Physiology of Neonates in Intensive Care
    Anticipated Study Start Date :
    May 1, 2021
    Anticipated Primary Completion Date :
    Dec 1, 2022
    Anticipated Study Completion Date :
    Dec 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Joint position [First week of life]

      Joint position

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • written informed parental consent
    Exclusion Criteria:

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Cambridge University Hospitals NHS Foundation Trust

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kathryn Beardsall, Principle Investigator, Cambridge University Hospitals NHS Foundation Trust
    ClinicalTrials.gov Identifier:
    NCT04831242
    Other Study ID Numbers:
    • Meerkat vs 1.0 1st Feb 2021
    First Posted:
    Apr 5, 2021
    Last Update Posted:
    Apr 5, 2021
    Last Verified:
    Apr 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 5, 2021